Conrad Z. Chan
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Programmable antibody-based chimeric entry receptors for sarbecoviruses.
Journal: Communications biology
Published: November 27, 2025
Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection Protocol.
Journal: Journal of medical virology
Published: June 20, 2024
Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
Journal: NPJ vaccines
Published: September 25, 2023
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
Journal: NPJ vaccines
Published: February 02, 2023
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults.
Journal: Infectious diseases and therapy
Published: June 17, 2022
Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus.
Journal: NPJ vaccines
Published: September 23, 2021
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
Journal: Cell
Published: November 18, 2020
TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants.
Journal: Scientific reports
Published: April 03, 2017
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
Journal: International journal of molecular sciences
Published: March 01, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026